Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Condition:   Pancreatic Cancer Interventions:   Drug: Pembrolizumab;   Drug: Olaparib Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   National Institute for Health Research, United Kingdom Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials